Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 6/20 | 0.41 |
| ▸ | MCHR1 | Q99705 | 7/20 | 0.36 |
| ▸ | CCNK | O75909 | 3/20 | 0.33 |
| ▸ | CDK12 | Q9NYV4 | 3/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.31 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.31 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4592558 | 0.89 | F10 (0.43) | F10MCHR1CCNKCDK12HDAC3 | |
| SCHEMBL4433785 | 0.89 | F10 (0.43) | F10MCHR1CCNKCDK12HDAC3 | |
| SCHEMBL4432476 | 0.88 | F10 (0.42) | F10MCHR1CCNKCDK12HDAC3 | |
| SCHEMBL8488819 | 0.87 | F10 (0.44) | F10 | |
| SCHEMBL3307569 | 0.87 | F10 (0.44) | F10 | |
| SCHEMBL13473889 | 0.87 | F10 (0.44) | F10 | |
| SCHEMBL4592517 | 0.86 | F10 (0.39) | F10MCHR1CCNKCDK12HDAC6 | |
| SCHEMBL4583302 | 0.85 | F10 (0.40) | F10MCHR1HDAC6 | |
| SCHEMBL13372904 | 0.85 | F10 (0.44) | F10MCHR1HDAC6 | |
| SCHEMBL4583647 | 0.85 | F10 (0.38) | F10MCHR1CCNKCDK12HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2132193-B1 | SUBSTITUTED PYRROLIDINE AMIDES, THE PRODUCTION THEREOF, AND THE USE THEREOF AS MEDICATIONS | BOEHRINGER INGELHEIM INT (DE) | 2012-10-24 | — | — | EP | disclosed |
| EP-1975165-A1 | Substituted pyrrolidinamides, their production and utilisation as medicine | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2008-10-01 | — | — | EP | disclosed |